NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmerican Electric ( AEP) was upgraded at Wells Fargo to outperform from market perform. Stock has underperformed over the past four months, but Wells Fargo said it recently had a constructive meeting with management. BlackBerry ( BBRY) was downgraded at Jefferies to hold from buy. $8 price target. Sub scale handset business undercuts MDM opportunity, Jefferies said. Blackberry was upgraded at Credit Suisse to neutral from underperform. $8 price target. Estimates slashed, but risks appear fully reflected in the stock, Credit Suisse said. Brady ( BRC) was downgraded at BMO Capital to underperform from market perform. $28 price target. Margins could be hurt, as the company invests more in the business, BMO Capital said.
Rockwell Collins ( COL) was downgraded at Credit Suisse to neutral from outperform. $68 price target. Company is facing another transition year in 2015, Credit Suisse said. CAI International ( CAP) was upgraded to buy. Catamaran ( CTRX) was downgraded at Morgan Stanley to market perform from outperform. Company trades at a premium to its peers and growth is maturing, Morgan Stanley said. 3D Systems ( DDD) was initiated with a buy rating at Bank of America/Merrill Lynch. $65 price target. Market should continue to grow over the coming quarters, BofA/Merrill said. Dreamworks ( DWA) was downgraded at B. Riley to neutral from buy. Valuation call, as the stock is up 55% over the past five months, B. Riley said.
Envision Healthcare ( EVHC) was initiated with a neutral rating at Goldman Sachs. Valuation call, based on a $26 price target, Goldman Sachs said. Envision Healthcare was initiated with a buy rating and $32 price target at UBS. Accelerated growth will come from health reform and its increased exposure to outsourced physician services, UBS said. KKR ( KKR) was upgraded to buy at TheStreet Ratings. Michael Kors ( KORS) was downgraded at Jefferies to hold from buy. $80 price target. Valuation call, said Jefferies. Southwest Airlines ( LUV) was upgraded at Bank of America/Merrill Lynch to neutral from underperform. $15 price target. Company should benefit from better domestic pricing, BofA/Merrill said.